SCHEMBL22155692

SCHEMBL22155692

Cc1cc(N)nc(N2CCC(C)(F)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
HRH4 Q9H3N8 3/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NPSR1 Q6W5P4 2/20 0.38
USP2 O75604 1/20 0.38
KIF18A Q8NI77 2/20 0.37
PKM P14618 1/20 0.36
PTPN11 Q06124 1/20 0.35
NOS3 P29474 3/20 0.35
NOS1 P29475 3/20 0.35
NOS2 P35228 3/20 0.35
GBA1 P04062 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22119420 0.89 NOS3 (0.44) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL22148753 0.89 KMT2A (0.51) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL31118753 0.83 GBA1 (0.48) KMT2AMEN1HRH4KIF18ANOS3
SCHEMBL30788620 0.80 HRH4 (0.58) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL22148449 0.80 HRH4 (0.58) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL31120933 0.79 NOS3 (0.38) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL30788632 0.79 NOS3 (0.41) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL29187344 0.79 NOS3 (0.41) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL31470240 0.79 KMT2A (0.35) KMT2AMEN1HRH4KDM4EHPGD
SCHEMBL24818277 0.78 KDM4E (0.36) KMT2AMEN1HRH4KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146973-A1 SYNTHESIS OF A KIF18A INHIBITOR AMGEN INC. (US) 2023-08-03 WO disclosed
WO-2020132649-A1 HETEROARYL AMIDES USEFUL AS KIF18A INHIBITORS AMGEN INC. (US) 2020-06-25 WO disclosed